BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 9494915)

  • 1. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second trimester serum tests for Down's Syndrome screening.
    Alldred SK; Deeks JJ; Guo B; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD009925. PubMed ID: 22696388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
    Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
    Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of free beta-hCG in antenatal screening for Down's syndrome.
    Wald N; Densem J; Stone R; Cheng R
    Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P; Bischof P; Marguerat P; Mermillod B
    Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine tests for Down's syndrome screening.
    Alldred SK; Guo B; Takwoingi Y; Pennant M; Wisniewski S; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011984. PubMed ID: 26662198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-marker serum screening for Down's syndrome.
    Wald NJ; Densem JW; Smith D; Klee GG
    Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
    Wald NJ; George L; Smith D; Densem JW; Petterson K
    Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
    Wald NJ; Cuckle HS; Densem JW; Stone RB
    Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
    Watt HC; Wald NJ; Smith D; Kennard A; Densem J
    Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.